logo
The Rise Of Digital Colleagues: The Management Science Of Agentic AI

The Rise Of Digital Colleagues: The Management Science Of Agentic AI

Forbes7 days ago
Pawan Anand, AVP of Communications, Media & Technology at Persistent, driving innovation in GenAI, Agentic AI, and Digital Engineering.
A couple of years ago, large-language models wowed organizations with instant prose and picture-perfect ads. It was cool but fleeting. What's arriving now are digital colleagues: agentic AI systems that plan, decide and act within live workflows. The 2025 Gartner Hype Cycle for Artificial Intelligence classified autonomous agents as 'transformational.'
Early pilots reveal a déjà vu risk: Autonomous models scale faster than the organizations meant to govern them. To keep 'move fast, break things' from replaying at enterprise scale, I use what I call the "Colleague Model"—three tightly coupled disciplines that turn eager agents into trusted teammates while still moving revenue needles.
1. Corporate Memory 2.0: Feeding Agents A Live Narrative
Humans make judgments by recalling prior wins, near misses and reprimands; agents, on the other hand, need a structured analog. Pointing a model at an amorphous data lake only breeds hallucinations. Instead, you must stream a time-sequenced event spine—orders, sensor pings, support tickets—through a narration layer that labels cause, effect and policy context.
In my experience, real-time, event-streamed AI slashes the time it takes to spot problems. Uber's engineering team notes that its ML-driven, streaming anomaly-detection platform halved incident-detection latency compared to previous batch pipelines. In the industry at large, I've seen online marketplaces detect and automatically stop duplicate refunds in minutes—something human auditors might not catch for weeks.
For leaders, this means you need to appoint a chief event steward—part historian, part data-ops lead—to maintain your corporate backstory. This will make it so every new agent sees the same truth.
2. Policy As Physics: Embedding Governance In Every Decision
Ethics slide decks don't stop a rogue API call, and they certainly won't restrain self-optimizing software. Instead, you can translate risk principles into reusable safety-rail functions that run at the decision edge—API gateways, workflow engines and even robotic PLCs. Each rail returns an 'allow,' 'review' or 'block.'
Attach confidence thresholds to sensitive actions. If a pricing agent wants to discount an order with only 60% certainty, it must request human review. The information commissioner champions this human-on-the-loop pattern. With guardrails stored, legal and compliance teams can tweak risk appetite as quickly as engineers push code—with no more 30-day breaks between approval and release.
Leaders should run a quarterly policy burn-down session. Outdated rules can become a visible backlog, ranked by exposure and scheduled for refactor.
3. Autonomy Scorecard: Balancing Gains, Oversight And Drift
Latency and token costs still matter, but a colleague earns trust by creating value and managing risk. Implement three board-level metrics and review them alongside revenue and CSAT:
• Autonomy Yield: Net revenue gained or costs avoided per 1,000 agent actions.
• Supervision Load: Human minutes spent monitoring or correcting those actions.
• Risk Drift Index: The share of actions escalated or rolled back by safety rails.
Firms that link AI metrics directly to P&L targets are twice as likely to hit ROI thresholds, per McKinsey's 2024 survey. The trio above keeps everyone honest: If yield climbs but drift explodes, autonomy becomes a liability.
This means leaders should compensate product owners on yield minus drift. Incentives shape behavior—digital and human alike.
Executives often ask, 'Great framework—but how do we start next week?' Try this condensed sprint:
• Day 1 Morning: Map the workflow you'll augment. Mark every digital event and analog gap.
• Day 1 Afternoon: Encode the three riskiest rules as safety-rail functions.
• Day 2 Morning: Pipe mock autonomy yield and risk drift into your BI tool.
• Day 2 Afternoon: Launch the agent in shadow mode. Compare its suggestions with human output and tune thresholds.
Most teams finish with a running prototype, a live scorecard and a backlog of gaps that must be improved before full deployment.
Some may still ask, "Why is this management science, and why does this work?" To them I say the following:
• Corporate memory 2.0 borrows from knowledge-management theory.
• Policy as physics mirrors real-time control-systems engineering.
• Autonomy scorecards align with incentive economics and portfolio theory.
With this approach, if you change a variable—tighten a confidence threshold, enrich an event type—you can predict shifts in yield or drift. That makes performance testable and the discipline teachable, both of which are the hallmarks of genuine management science.
The Winning Play
Scientific management harnesses muscle. Statistical quality delivers precision. Agile unleashes creativity. Agentic management will marshal independent decision-making. Deploying digital colleagues—AI agents—will soon be table stakes; stewarding their judgment will be the differentiator.
Start now, and the most sought-after résumé in your pipeline may belong to a line of code your teams request by name.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Inari Amertron Berhad's (KLSE:INARI) earnings have declined over year, contributing to shareholders 39% loss
Inari Amertron Berhad's (KLSE:INARI) earnings have declined over year, contributing to shareholders 39% loss

Yahoo

time6 minutes ago

  • Yahoo

Inari Amertron Berhad's (KLSE:INARI) earnings have declined over year, contributing to shareholders 39% loss

While it may not be enough for some shareholders, we think it is good to see the Inari Amertron Berhad (KLSE:INARI) share price up 13% in a single quarter. But that doesn't change the reality of under-performance over the last twelve months. The cold reality is that the stock has dropped 41% in one year, under-performing the market. The recent uptick of 6.5% could be a positive sign of things to come, so let's take a look at historical fundamentals. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Unfortunately Inari Amertron Berhad reported an EPS drop of 29% for the last year. The share price decline of 41% is actually more than the EPS drop. This suggests the EPS fall has made some shareholders more nervous about the business. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. A Different Perspective While the broader market lost about 3.7% in the twelve months, Inari Amertron Berhad shareholders did even worse, losing 39% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Longer term investors wouldn't be so upset, since they would have made 2%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for Inari Amertron Berhad that you should be aware of. Of course Inari Amertron Berhad may not be the best stock to buy. So you may wish to see this free collection of growth stocks. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Morning Bid: Buy the dip, we can worry about jobs later
Morning Bid: Buy the dip, we can worry about jobs later

Yahoo

time6 minutes ago

  • Yahoo

Morning Bid: Buy the dip, we can worry about jobs later

(Reuters) -A look at the day ahead in European and global markets from Wayne Cole. It's been a case of buy the dip so far on Monday as U.S. and European stock futures edge up, along with the dollar. The Nikkei suffered a delayed reaction to Friday's Wall Street rout and a jump in the yen, but the rest of Asia fared better. Early trade saw Fed fund futures price in 65 bps of interest rate cuts by December, but that's back to 60 bps now. That's still a world away from the 33 bps seen before Friday's weak U.S. payrolls report, and September is still 83% for an easing. In fact, the 25 bps drop in two-year yields on Friday was essentially the market doing a Fed rate cut for them, given how borrowing costs in the States are tied to yields not the funds rate. Ten-year yields also fell a steep 14 bps but met resistance around 4.20%, a level they have repeatedly struggled to break under since October last year. Longer term, downward revisions to payrolls have seriously challenged the U.S. claim to economic out-performance and the dollar's crown of exceptionalism. The latter was also tarnished by President Trump firing the head of the Bureau of Labor Statistics, an institution with an invaluable reputation for scrupulous honesty that won the trust of investors worldwide. Or, at least, it used to be. Now, Trump says he will chose a new head for the BLS in the next few days. Will it be an independent-minded statistician dedicated to providing credible data, or a Trump loyalist eager to please their master? U.S. assets enjoy a trust premium that will be really hard to maintain as Trump bends all levels of government to his will. Trump also just floated the idea of using some of the windfall from tariffs to pay "dividends" to a lucky group of Americans chosen by him - no doubt with special cheques bearing a "TRUMP" logo. So you slap taxes on everyone that buys imports, whether they have a choice or not, and then use part of the revenue to pay money to those you favour, in your name rather than the government that's actually doing the work. Talking of tariffs, a U.S. appeals court late last week heard arguments on the legality of Trump's "reciprocal" levies and sounded inclined to support the original ruling that the tariffs were illegal. Such a ruling would likely still go to the Supreme Court, which has tended to favour unbridled presidential power. Yet, should the tariffs be found illegal, not only would all the trade deals agreed or underway be null and void, but the Treasury would have to refund all the money collected. Wouldn't that be fun... Key developments that could influence markets on Monday: * Swiss CPI for July Trying to keep up with the latest tariff news? Our new daily news digest offers a rundown of the top market-moving headlines impacting global trade. Sign up for Tariff Watch here. (By Wayne Cole; Editing by Christopher Cushing) Sign in to access your portfolio

Discovering Asia's Undiscovered Gems This August 2025
Discovering Asia's Undiscovered Gems This August 2025

Yahoo

time6 minutes ago

  • Yahoo

Discovering Asia's Undiscovered Gems This August 2025

As global markets grapple with renewed trade tensions and economic uncertainties, smaller-cap indices have experienced notable declines, reflecting the broader market sentiment. Amid this backdrop, investors are increasingly on the lookout for resilient stocks that can navigate these challenges and offer potential growth opportunities. In Asia's dynamic landscape, identifying such undiscovered gems requires a keen understanding of local markets and a focus on companies with strong fundamentals and innovative strategies. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating Chudenko NA 4.69% 17.78% ★★★★★★ Wuxi Chemical Equipment NA 13.24% -0.17% ★★★★★★ Minmetals Development 35.99% 0.88% -12.63% ★★★★★★ Jiangyin Haida Rubber And Plastic 16.31% 7.95% -9.56% ★★★★★★ Shantou Institute of Ultrasonic Instrument NA 17.40% 16.47% ★★★★★★ Yashima Denki 2.36% 1.42% 23.63% ★★★★★☆ Hangzhou Zhengqiang 26.03% 2.95% 16.75% ★★★★★☆ Jinsanjiang (Zhaoqing) Silicon Material 3.59% 18.23% -7.68% ★★★★★☆ Ningbo Henghe Precision IndustryLtd 66.02% 5.50% 23.91% ★★★★☆☆ Zhejiang Risun Intelligent TechnologyLtd 27.20% 20.30% -23.01% ★★★★☆☆ Click here to see the full list of 2576 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. Let's review some notable picks from our screened stocks. COSCO SHIPPING International (Singapore) Simply Wall St Value Rating: ★★★★☆☆ Overview: COSCO SHIPPING International (Singapore) Co., Ltd. is an investment holding company that offers integrated logistics services across South and Southeast Asia, with a market capitalization of SGD550.85 million. Operations: COSCO SHIPPING International (Singapore) derives its revenue primarily from logistics, contributing SGD149.87 million, and ship repair and marine-related activities, which add SGD20.14 million. Property management also contributes to the revenue with SGD3.45 million. The company's financial performance is influenced by its net profit margin trends over the periods analyzed. COSCO SHIPPING International (Singapore) showcases a stable financial footing with a net debt to equity ratio of 22.1%, deemed satisfactory, and interest payments well covered by EBIT at 3.7 times. Despite an impressive earnings growth of 188.1% over the past year, it slightly lagged behind the broader logistics industry at 193.5%. The company has been proactive in expanding its operations, with construction underway for the Jurong Island Logistics Hub Phase II, expected to complete by late 2026. However, shareholders faced substantial dilution recently due to a SGD 273 million rights offering completed in July 2025. Delve into the full analysis health report here for a deeper understanding of COSCO SHIPPING International (Singapore). Assess COSCO SHIPPING International (Singapore)'s past performance with our detailed historical performance reports. Chongqing Pharscin Pharmaceutical Simply Wall St Value Rating: ★★★★★★ Overview: Chongqing Pharscin Pharmaceutical Co., Ltd. is a company involved in the pharmaceutical industry with a market capitalization of CN¥8.66 billion. Operations: Pharscin generates its revenue primarily from pharmaceutical sales. The company recorded a market capitalization of CN¥8.66 billion. Chongqing Pharscin Pharmaceutical stands out with its recent earnings surge of 78.7%, significantly outperforming the broader Pharmaceuticals industry, which saw a -2.6% change. Despite a volatile share price over the last three months, the company maintains a debt-free status, contrasting sharply with its previous debt to equity ratio of 20.9% five years ago. A notable CN¥22.6M one-off gain has influenced recent financial outcomes, highlighting some irregularities in earnings quality. The approval of a cash dividend for 2024 and changes in board composition underscore ongoing strategic adjustments within this dynamic pharmaceutical player in Asia's market landscape. Dive into the specifics of Chongqing Pharscin Pharmaceutical here with our thorough health report. Learn about Chongqing Pharscin Pharmaceutical's historical performance. Beijing Scitop Bio-tech Simply Wall St Value Rating: ★★★★★★ Overview: Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, manufacturing, and sale of probiotic lactic acid bacteria and related products in China with a market capitalization of CN¥5.38 billion. Operations: Scitop Bio-tech generates revenue primarily from the sale of probiotic lactic acid bacteria products. The company has a market capitalization of CN¥5.38 billion, reflecting its financial stature in the industry. Beijing Scitop Bio-tech, a smaller player in the biotech sector, has shown resilience with high-quality earnings and no debt over the past five years. Despite a volatile share price recently, its earnings growth of 4.6% last year surpassed the broader food industry's -5% trend. However, its free cash flow remains negative at -139.99 million CNY as of March 2025, indicating potential challenges in liquidity management. The company approved a cash dividend of CNY 1.50 per ten shares for 2024, reflecting confidence despite declining earnings by 1% annually over five years. Click here and access our complete health analysis report to understand the dynamics of Beijing Scitop Bio-tech. Evaluate Beijing Scitop Bio-tech's historical performance by accessing our past performance report. Summing It All Up Click this link to deep-dive into the 2576 companies within our Asian Undiscovered Gems With Strong Fundamentals screener. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SGX:F83 SZSE:002907 and SZSE:300858. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store